Call for Abstracts

The scientific committee is pleased to invite you to submit abstracts for consideration at the EHSF 2017. Make sure to be part of the conference and present your latest study results in the field of Dermatology.



Submission Deadline

Abstract submission is solely possible via the online abstract portal until 2 January 2017. Please select one category out of the topics that best describes the content of your abstract. Kindly note that the final decision will be made by the scientific committee.

Abstract Topics

Please submit your abstract by selecting one category out of the following that best describes its scientific content. Categories will be used for reviewing and indexing purposes.

  • Epidemiology and registries
  • Adjuvant therapy
  • Handicap
  • Medical treatment
  • Comorbidities
  • Genetics
  • Syndromic HS
  • Immunology
  • Clinical classification
  • Other treatments
  • Microbiology
  • Innovative Research
  • Outcome measures
  • Imaging
  • Case presentation
  • Surgery
  • Endocrinology
  • Histopathology

Abstract Guidelines

  • Abstract text is limited to 3,000 characters
  • Abstracts must be submitted in British English
  • Up to 1 table and 1 graphic/picture can be used
  • All abstracts must contain original work that has not been published or presented on previous occasions.
  • Please indicate your preferred type of presentation (oral or poster) and choose a topic from the drop-down list.
  • Please check spelling and grammar carefully. All abstracts will be published as submitted.

Please structure your abstract as follows:

  • Objectives
  • Methods
  • Results
  • Conclusion


Please note that the acceptance of your abstract does not include congress registration. We kindly ask for at least one author (the first or the presenting author) to register for the congress. Otherwise, the abstract will not be reviewed and will be dismissed by the scientific committee.

Presentation Types

  • Oral presentation or poster
  • Oral presentation
  • Poster presentation

Submitted abstracts will be carefully reviewed. The scientific committee will decide on the acceptance of abstracts. Notifications of acceptance will be sent in writing.


MCI Deutschland GmbH
MCI | Berlin Office
Markgrafenstr. 56
10117 Berlin, Germany
T +49 30 204590
F +49 30 2045950
Scientific Organisation
European Hidradenitis Suppurativa Foundation e.V.
Legal Organiser & PCO
MCI Deutschland GmbH
MCI | Berlin Office
Markgrafenstr. 56
10117 Berlin, Germany
P: +49 30 204590
F: +49 30 2045950
E: ehsf@mci-group.com
Conference Venue
Tietgensgade 65
1704 Copenhagen V


Legal Notice